Intranasal Esketamine Treatments

Robust evidence from randomised controlled trials and meta-analyses supports the efficacy of intranasal esketamine in reducing depressive symptoms in adults with TRD, including those with severe and refractory illness . A key clinical advantage is its rapid onset of action, often producing symptomatic improvement within hours to days, compared to weeks for conventional antidepressants . Esketamine is typically administered under supervision in combination with an oral antidepressant, following an induction and maintenance schedule, reflecting both efficacy and safety considerations . Long-term studies further demonstrate sustained benefits with an acceptable safety profile when delivered within structured clinical settings .

In Australia, regulatory frameworks emphasise specialist-led delivery, with psychiatrists responsible for patient selection, prescribing, and monitoring due to the medication’s Schedule 8 status and potential risks . This underscores the importance of specialised centres capable of providing comprehensive assessment, medical oversight, and multidisciplinary care.

Within this context, Therapeutic Brain Stimulation (TBS) Melbourne is well positioned to deliver esketamine treatment as part of an integrated, evidence-based approach to TRD. Leveraging expertise in neuromodulation therapies such as transcranial magnetic stimulation (TMS) and electroconvulsive therapy (ECT), TBS Melbourne offers a highly specialised environment for patient selection, protocol-driven administration, and outcome monitoring. Such centres play a critical role in translating emerging biological treatments into safe, scalable clinical practice, ensuring that patients with complex and refractory depression have access to innovative and potentially life-changing interventions.

Medicare Funded Esketamine Treatments have specific eligibility criteria ( MBS Online)

Please contact us to determine your eligibility for Medicare criteria for Intranasal Esketamine Treatment

Upon receiving a referral from your GP or Psychiatrist, our credentialled Psychiatrists assess the patient for suitability of Medicare Funded Esketamine Treatments. The referral can be emailed to admin@camberwellspecialists.com.au

Other services

Psychiatric Assessments

Ongoing psychiatric care

Psychology

Second Opinion Services

Telehealth Options

CLINICAL SUPERVISION

Why Chose Camberwell Specialists?

Comprehensive, Evidence-Based Care

Camberwell Specialists pride themselves on offering cutting-edge, evidence-based treatments tailored to each individual’s unique mental health challenges. From anxiety and depression to trauma and complex psychiatric disorders, our team uses proven therapeutic modalities like cognitive-behavioral therapy (CBT), psychodynamic therapy, and advanced interventions like rTMS and medication management to deliver the highest standard of care.

Highly Skilled and Compassionate Team

Our team consists of experienced psychologists, psychiatrists, and mental health specialists dedicated to your well-being. We combine clinical expertise with empathy to create a safe, supportive space where you can openly address your concerns and work towards meaningful growth. We prioritize building a strong therapeutic relationship, ensuring every patient feels heard, respected, and empowered throughout their journey.

Personalized, Patient-Centered Approach

At Camberwell Specialists, we understand that mental health needs vary widely. That’s why we provide personalized treatment plans tailored to your specific goals, preferences, and circumstances. Whether you require short-term support, long-term therapy, or innovative treatments, we collaborate with you to ensure the care you receive aligns with your needs, helping you achieve a healthier and more fulfilling life.